As of January 22, 2025, Fagron (FAGR.BR) has a market cap of $1.37 billion USD. According to our data, Fagron is ranked No.4728 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.37 B |
7.76%
|
Dec 31, 2024 | $1.27 B |
2.53%
|
Dec 29, 2023 | $1.24 B |
27.02%
|
Dec 30, 2022 | $0.98 B |
-9.25%
|
Dec 31, 2021 | $1.08 B |
-21.37%
|
Dec 31, 2020 | $1.37 B |
-1.31%
|
Dec 31, 2019 | $1.39 B |
36.30%
|
Dec 31, 2018 | $1.02 B |
25.96%
|
Dec 29, 2017 | $0.81 B |
17.52%
|
Dec 30, 2016 | $0.69 B |
53.57%
|
Dec 30, 2015 | $0.45 B |
-79.82%
|
Dec 31, 2014 | $2.22 B |
27.94%
|
Dec 31, 2013 | $1.73 B |
84.18%
|
Dec 28, 2012 | $0.94 B |
45.23%
|
Dec 30, 2011 | $0.65 B |
0.88%
|
Dec 30, 2010 | $0.64 B |
46.37%
|
Dec 31, 2009 | $0.44 B |
34.62%
|
Dec 31, 2008 | $0.33 B |
-31.99%
|
Dec 31, 2007 | $0.48 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Perrigo
PRGO
|
$3.28 B |
0.000 M
|
Ireland
|
Bausch Health
BHC
|
$2.85 B |
6.423 M
|
Canada
|
Catalent
CTLT
|
$11.52 B |
0.000 M
|
USA
|
West Pharmaceutical
WST
|
$25.19 B |
0.001 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$219.73 B |
0.006 M
|
USA
|
Charles River Laboratories
CRL
|
$8.60 B |
-0.000 M
|
USA
|
BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
Market Cap | = | FAGR.BR Stock Price | * | FAGR.BR Shares Outstanding |
= | $18.80 | * | 72.84 M | |
= | $1.37 B |